先看重點
在納入9項隨機試驗(其中6項進入統合分析)的綜述中,與較高血糖指數飲食或對照飲食相比,低血糖指數(低GI)飲食降低了2型糖尿病患者的HbA1c和空腹血糖(HbA1c的P均<0.001)。各試驗結果並不一致,4項研究的HbA1c無顯著差異,摘要也未給出合併效應量。
證據類型
隨機試驗統合分析
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
低GI飲食被提議用於糖尿病的血糖管理,但各試驗結論不一,長期使用的效果也不清楚。研究者綜述了低GI飲食在2型糖尿病患者中的隨機試驗。
研究對象與方法
對2008至2018年發表的2型糖尿病成人隨機對照試驗進行系統綜述和統合分析,透過PubMed、EBSCOHost和灰色文獻,按PICOS框架篩選。排除妊娠期糖尿病、1型糖尿病和觀察性研究。9篇文章進入系統綜述,6篇進入統合分析。使用Review Manager 5.3評估質量、偏倚風險、異質性和敏感性。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1有2項研究顯示HbA1c顯著改善(變化值):低GI飲食為-0.5%(95%CI -0.61%至-0.39%),高穀物纖維飲食為-0.18%(95%CI -0.29%至-0.07%);低GI豆類飲食為-0.5%(95%CI -0.6%至-0.4%),高小麥纖維飲食為-0.3%(95%CI -0.4%至-0.2%)。
- 2有1項研究顯示輕微改善(6.5%對比對照組的6.6%),4項研究的HbA1c沒有顯著差異(P>0.05)。
- 34項研究報告低GI飲食的空腹血糖更好,但結果不一:其中一項為127.7對136.8 mg/dL(P=0.02),另一項為7.3對7.7 mmol/L(P<0.05),其餘兩項差異不顯著(P=0.43和P>0.05)。
- 4統合分析顯示低GI飲食在HbA1c上具有顯著優勢(P<0.001,敏感性分析的P也<0.001),空腹血糖也有顯著優勢(P<0.05)。
限制與不確定性
- 1僅合併了6項試驗,摘要沒有報告合併效應量、置信區間和異質性,因此獲益的大小並不明確。
- 2對照飲食各不相同(較高GI飲食、高纖維飲食、標準糖尿病飲食或常規交換飲食),合併比較混合了不同的對照。
- 3各項研究結果不一致,包括4項HbA1c無顯著差異的研究,這使得結論沒那麼確定。
- 4只納入了2008至2018年的試驗,且本解讀僅依據摘要。
日常健康啟示
選擇低GI食物可能對2型糖尿病的血糖控制有一定幫助,但證據並不一致,摘要也沒有說明獲益的大小。糖尿病患者調整飲食應與臨床醫師或營養師商量,尤其是正在使用降糖藥物的人。
如何連結自己的資料
連續血糖監測、指尖血糖記錄或飲食日誌可以顯示某一餐後的血糖反應,而這些試驗中的HbA1c反映的是數月的整體控制。請在相似的時間比較相似的餐食,使用同一臺血糖儀,並關注數週的趨勢,而不是單次讀數。
如何理解這類證據
合併試驗可提高精確度,但族群、對照、偏誤與不確定性仍重要;網路排名包含間接證據,不是通用最佳方案。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
The increasing prevalence of diabetes in the United Kingdom and worldwide calls for new approaches to its management, and diets with low glycaemic index have been proposed as a useful means for managing glucose response. However, there are conflicting reports and differences in the results of studies in terms of their effectiveness. Furthermore, the impact of low-glycaemic index diets and their long-term use in patients with type 2 diabetes remains unclear.
Objectives
The objective of this study was to conduct a systematic review and meta-analysis of the effect of low-glycaemic index diets in patients with type 2 diabetes.
Methods
Search methods: Randomised controlled studies were selected from a number of databases (EBSCOHost with links to Health Research databases, PubMed, and grey literature) based on the Population, Intervention, Comparator, Outcomes and Study designs (PICOS) framework. The search terms included synonyms and Medical Subject Headings (MeSH) and involved the use of Boolean operators (AND/OR) which allowed the combination of words and search terms.
Selection criteria
As per the selection criteria, the following types of articles were selected: studies on randomised controlled trials, with year of publication between 2008 and 2018, including patients with type 2 diabetes. Thus, studies involving patients with gestational and type 1 diabetes were excluded, as were observational studies. Nine articles which met the inclusion criteria were selected for the systematic review, whereas only six articles which met the criteria were included in the meta-analysis.
Data collection and analysis
Studies were evaluated for quality and risk of bias. In addition, heterogeneity, meta-analysis, and sensitivity tests of the extracted data were carried out using Review Manager 5.3 (Review Manager, 2014).
Results
The findings of the systematic review showed that the low-glycaemic index (low-GI) diet resulted in a significant improvement (<0.05) in glycated haemoglobin (HbA1c) in two studies: low-GI diet Δ = -0.5% (95% CI, -0.61% to -0.39%) vs. high-cereal fibre diet Δ = -0.18% (95% CI, -0.29% to -0.07%); and low-GI legume diet Δ = -0.5% (95%, -0.6% to -0.4%) vs. high-wheat fibre diet Δ = -0.3% (95% Cl, -0.4 to -0.2%). There was a slight improvement in one study (low glycaemic response = 6.5% (6.3-7.1) vs. control = 6.6% (6.3-7.0) and no significant difference ( p > 0.05) in four studies compared with the control diet. Four studies showed improvements in fasting blood glucose in low-GI diets compared to higher-GI diets or control: low-GI diet = 150.8 ± 8.7 vs. higher-GI diet = 157.8 ± 10.4 mg/dL, mean ± SD p = 0.43; low-GI diet = 127.7 vs. high-cereal fibre diet = 136.8 mg/dL, p = 0.02; low-GI diet = 6.5 (5.6-8.4) vs. standard diabetic diet = 6.7 (6.1-7.5) mmol/L, median and interquartile range p > 0.05; and low-GI diet = 7.3 ± 0.3 vs. conventional carbohydrate exchange diet = 7.7 ± 0.4 mmol/L, mean ± SEM (Standard Error of Mean) p < 0.05. The results of the meta-analysis and sensitivity tests demonstrated significant differences ( p < 0.001 and p < 0.001, respectively) between the low-GI diet and the higher-GI diet or control diet in relation to glycated haemoglobin. Differences between the low-GI diet and higher-GI diet or control were significant ( p < 0.05) with respect to the fasting blood glucose following meta-analysis.
Conclusion
The low-GI diet is more effective in controlling glycated haemoglobin and fasting blood glucose compared with a higher-GI diet or control in patients with type 2 diabetes.
來源與署名
The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ojo O, Ojo OO, Adebowale F, Wang XH.
Nutrients · 2018-03-19
DOI: 10.3390/nu10030373 ↗PubMed · 29562676 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
更早的進食視窗與更大的體重和胰島素獲益相關,優於晚間進食
彙總41項隨機對照試驗(2287名參與者,介入時間中位數8週)發現,限時進食比日常飲食體重低2.15 kg(95%置信區間−2.56至−1.74),而早吃比晚吃體重多降1.15 kg(95%置信區間−1.86至−0.45)。多數試驗較短,只有6個研究組檢驗了早間進食,結局是身體和血液指標,不是心臟病發作或死亡。
BMJ Medicine
限熱量飲食再加上午8點至下午4點進食視窗,1年減重無明顯額外優勢
139名肥胖患者都按限制熱量的飲食進食,其中一組再加上上午8:00至下午4:00的進食視窗,12個月平均體重變化為−8.0 kg,單純限熱量組為−6.3 kg。淨差值−1.8 kg(95%置信區間−4.0至0.4;P=0.11)無統計學意義,該區間既不能排除視窗確有獲益,也不能排除毫無作用。
The New England Journal of Medicine
20人住院試驗:超加工飲食讓人每天多攝取508 kcal並增重
20名成年人在醫院研究病房住了28天,兩種選單各吃2週、想吃多少吃多少:超加工選單讓他們每天多攝取508 kcal(±106,標準誤,P=0.0001),體重增加0.9 kg;未加工選單則讓體重減輕0.9 kg。樣本小、週期短、食物全程由研究方提供,既不能說明日常生活中的長期結果,也無法確定是食物的哪種特點導致多吃。
Cell Metabolism
地中海飲食加橄欖油或堅果與心血管事件減少相關(更正後的試驗)
在7447名55至80歲、心血管風險較高的西班牙成年人中,被分到加特級初榨橄欖油(風險比0.69,95%置信區間0.53至0.91)或加堅果(風險比0.72,0.54至0.95)的地中海飲食組,發生主要心血管事件的風險低於被告知減少脂肪的對照組。試驗存在隨機化失誤,2013年的報告已撤回並重新估算,證據有力但並不完美。
The New England Journal of Medicine

